Visual Loss Induced by Adalimumab Used for Plaque Psoriasis
A 61-year-old Caucasian male with severe plaque psoriasis without joint involvement was initiated on adalimumab therapy. Shortly thereafter he presented to the emergency room with acute loss of vision in the right eye. A comprehensive systemic workup was instituted which included magnetic resonance...
Saved in:
Main Authors: | Norman Saffra (Author), Konstantin Astafurov (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
by: Nicolazzo D, et al.
Published: (2014) -
Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature
by: Angela Y Moore, et al.
Published: (2010) -
Severe plaque psoriasis with coexisting cicatricial alopecia treated with adalimumab - case report
by: Dorota Krasowska, et al.
Published: (2014) -
Comparision of the efficacy and safety between Secukinumab and Adalimumab in the treatment of the moderate to severe plaque psoriasis
by: Dandan HU, et al.
Published: (2023) -
Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
by: Chu Y, et al.
Published: (2022)